• Info
  • Insider Trading

Insider Transactions Reported by 7 Insiders of Polaryx Therapeutics, Inc.

Symbol
PLYX on Nasdaq
Location
Paramus, NJ

There are no Buy or Sell transactions made by insiders since 11 Mar 2025

Polaryx Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alex Keun Mo Yang Chief Executive Officer, Director, 10%+ Owner $70,502,804 29 Jan 2026
John O Andrew Chief Investment Officer $1,377,679 29 Jan 2026
G. Michael Landis Chief Financial Officer, Director $666,417 18 Feb 2026
Lisa Bollinger Chief Medical Officer $439,045 29 Jan 2026
Mitchel Berger Director 29 Jan 2026
Charles S. Ryan Director 29 Jan 2026
III Francis A. Braun Director 29 Jan 2026

Recent Insider Transactions by Companies or Individuals for Polaryx Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.